Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROCEPT BioRobotics Corp Director's Dealing 2021

Sep 15, 2021

31665_dirs_2021-09-14_81e61a99-b56a-4e33-9c64-fee12d2f64ad.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PROCEPT BioRobotics Corp (PRCT)
CIK: 0001588978
Period of Report: 2021-09-14

Reporting Person: Harris Taylor C. (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series E Convertible Preferred Stock $ Common Stock (31215.0) Indirect
Series G Convertible Preferred Stock $ Common Stock (3859.0) Indirect
Stock Option (Right to Buy) $5.1775 2030-12-16 Common Stock (95473.0) Direct

Footnotes

F1: Each share of Series A Preferred Stock , Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock (collectively, the "Preferred Stock") will convert automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date.

F2: The Stock option was granted on December 16, 2020 and vests on each monthly anniversary of the grant date over a 4 year period, subject continued employment or service to the Issuer through the applicable vesting date.